Brimonidine - Clinical Pharmacology. Mechanism of Action: Brimonidine Tartrate Ophthalmic Solution, 0.2% is an alpha adrenergic receptor agonist.
Brimonidine (Alphagan, Alphagan P - Discontinued in the US) is a drug prescribed for the treatment of open-angle glaucoma. Side effects, drug interactions, and ...
Learn about the prescription medication Alphagan-P (Brimonidine Tartrate), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling.
Find patient medical information for brimonidine ophthalmic on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.
Brimonidine. Authoritative facts about the skin from DermNet New Zealand.
Brimonidine (bri-MOE-ni-deen) is a drug used as eye drops under the brand names Alphagan and Alphagan-P to treat open-angle glaucoma or ocular hypertension, and as a ...
Brimonidine is an imidazole derivative and a selective alpha-2 adrenergic receptor agonist. Upon ocular administration, brimonidine acts on the blood vessels causing ...
Into the eye. Brimonidine ophthalmic (eye) drops is used alone or together with other medicines to treat increased pressure in the eye that is caused by open-angle…
brimonidine [brĭ-mo´nĭ-dēn] an alpha-adrenergic receptor agonist used as the tartrate salt in treatment of open-angle glaucoma and ocular hypertension ...
Information for Patients. The preservative in brimonidine tartrate ophthalmic solution 0.2%, benzalkonium chloride, may be absorbed by soft contact lenses.